Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? (Q37778640)

23 August 2017

title

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? (English)

1 reference

23 August 2017

1 reference

Johan W Mouton

2

0 references

David M. Livermore

6

object named as

David M Livermore

1 reference

23 August 2017

Stephanie A Chisholm

1

1 reference

23 August 2017

David A Lewis

3

1 reference

23 August 2017

Tom Nichols

4

1 reference

23 August 2017

Catherine A Ison

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

6 August 2010

1 reference

Journal of Antimicrobial Chemotherapy

23 August 2017

published in

1 reference

23 August 2017

volume

65

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

2141-2148

1 reference

Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

The Neisseria gonorrhoeae population in Sweden during 2005-phenotypes, genotypes and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Pharmacokinetic Determinants of Penicillin Cure of Gonococcal Urethritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Which cephalosporin for gonorrhoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Anti-infective strategies of the future: is there room for species-specific antibacterial agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

Recent advances in bacterial topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ289

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ289

1 reference

23 August 2017

1 reference